Trials / Sponsors / W. Dalton Dietrich
W. Dalton Dietrich
Academic / Other · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PN Peripheral Nerve Injury | Phase 1 | 2023-05-04 |
| Completed | Autologous Human Schwann Cells in Peripheral Nerve Repair Peripheral Nerve Injuries | Phase 1 | 2019-09-24 |
| Completed | The Safety of ahSC in Chronic SCI With Rehabilitation Spinal Cord Injury, Paraplegia, Quadriplegia | Phase 1 | 2015-01-01 |
| Completed | Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI Spinal Cord Injury, Paraplegia | Phase 1 | 2012-11-01 |
| No Longer Available | Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair Peripheral Nerve Injuries | — | — |
| No Longer Available | Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Rep Sciatic Nerve Injury | — | — |
| No Longer Available | Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury. Sciatic Nerve Injury | — | — |